Overview
The Therapeutic Aspects of CytoSorb Therapy
Supporting healthcare professionals in maintaining physiological balance.
CytoSorb® Therapy provides a hemoadsorption option designed to support the reduction of selected inflammatory mediators, helping to maintain physiological stability in critically ill patients. The therapy is intended to remove or reduce excessive levels of inflammatory mediators and other circulating molecules that, at elevated levels, may be harmful to the body. Published clinical experience has reported associations with parameters such as hemodynamic stability, tissue perfusion, and organ function when CytoSorb® Therapy is applied as part of a multimodal critical-care approach.
The CytoSorb® adsorber is an extracorporeal blood purification technology designed to reduce selected substances from blood or plasma that, at excessive levels, may be harmful to the body. It can be used in various clinical settings where hemoadsorption may support the management of inflammatory or substance-related imbalances as part of a multimodal treatment strategy.
-
CytoSorb® Therapy provides a hemoadsorption option designed to support the reduction of selected inflammatory mediators, helping to maintain physiological stability in critically ill patients. The therapy is intended to remove or reduce excessive levels of inflammatory mediators and other circulating molecules that, at elevated levels, may be harmful to the body. Published clinical experience has reported associations with parameters such as hemodynamic stability, tissue perfusion, and organ function when CytoSorb® Therapy is applied as part of a multimodal critical-care approach.
-
The CytoSorb® adsorber is an extracorporeal blood purification technology designed to reduce selected substances from blood or plasma that, at excessive levels, may be harmful to the body. It can be used in various clinical settings where hemoadsorption may support the management of inflammatory or substance-related imbalances as part of a multimodal treatment strategy.
Here, you can find more information on CytoSorb® Therapy and its application across different medical specialties. This section includes details on patient selection, timing, and dosing, as well as access to current published clinical research.
Use of CytoSorb in therapeutic areas
-
Critical Care
CytoSorb is a unique technology proven to effectively and safely reduce elevated levels of cytokines, inflammatory mediators, many bacterial toxins, and substances such as bilirubin and myoglobin. The goal of therapy is to protect vital organs and reduce the severity of organ damage.
-
Cardiovascular Care
Use of CytoSorb Therapy can help speed up hemodynamic stabilization and reduce the need for organ support therapies. This technology has demonstrated benefits for cardiovascular patients with, or at high risk of, hyperinflammation or at risk of bleeding due to ticagrelor or rivaroxaban.
-
Liver Care
CytoSorb is one of the easiest-to-use and most capable extracorporeal liver support therapies. Unlike dialysis-based therapies, CytoSorb Therapy effectively and simultaneously removes both cytokines and liver toxins – helping to reduce inflammation, unburden the liver to promote liver recovery, and in fulminant cases – bridge to transplant.
-
Kidney Care
CytoSorb is a unique technology proven to effectively, safely, and simultaneously reduce elevated levels of cytokines and myoglobin, thereby supporting the restoration of renal function. Hemoadsorption goes beyond renal replacement therapies and significantly reduces inflammatory mediators and metabolites.
Proven safety
Over 250,000 hemoadsorption treatments over the last ten years.
Most peer-reviewed adsorber
Over 1,100 publications, abstracts, posters, manuscripts, and other resources.
Improved patient outcomes
With demonstrated efficacy across cardiovascular, hepatic, kidney, and critical care.
Simple system integration
Starting patient treatment with CytoSorb technology is fast and easy, with less work for nurses, and greater peace of mind.
Proprietary bead technology
Each CytoSorb cartridge features ISO 10993-certified porous polymer beads, for biocompatibility and hemocompatibility.
Concentration-dependent and size-dependent removal
Effective removal of cytokines, bilirubin, myoglobin, rivaroxaban, and ticagrelor—and minimal removal of important substances such as albumin.
Voices around the world
Access Healthcare Professionals Area
This area is for Health Care Professionals only and provides reports about clinical experiences gained during the use of CytoSorbents products. The information presented reflects the opinions and procedural techniques of individual physicians and is not intended as medical advice. Physician experience, risks, patient outcomes and results may vary. This content is intended for Health Care Professionals outside the United States and Canada as CytoSorb has not yet been approved or cleared in the United States or Canada for any indication, except under an Emergency Use Authorization (EUA) by the US FDA.